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In the current study, we compared the effect of thrombin on Ca 2ϩ signaling in human PAEC and PASMC. Our results show that thrombin-mediated intracellular Ca 2ϩ mobilization involves different stores in PAEC and PASMC. Importantly, we identify a novel thrombin-releasable store in PAEC that is insensitive to cyclopiazonic acid (CPA), caffeine, and ryanodine, which may be crucial in understanding the pathogenesis of diseases such as chronic thromboembolic pulmonary hypertension (CTEPH), where pulmonary arteries are particularly exposed to thrombin.
MATERIALS AND METHODS
Cell preparation and culture. Human PASMC and PAEC from normal subjects purchased from Lonza were used for experiments. Cryopreserved cells were plated onto cover slips or Petri dishes and incubated in a humidified atmosphere of 5% CO 2 in air at 37°C in smooth muscle growth medium (SMGM; Lonza) for PASMC and in endothelium growth medium (EGM; Lonza) for PAEC. SMGM was composed of smooth muscle basal medium supplemented with 5% FBS, human epidermal growth factor, human fibroblast growth factor, and insulin. EGM was composed of endothelium basal medium supplemented with 2% FBS, human epidermal growth factor, human fibroblast growth factor, and insulin. PASMC and PAEC were used for experiments between passages 2 and 6. The morphology of the cells was examined using phase contrast microscopy.
Measurement of [Ca 2ϩ ]cyt. Cytosolic Ca 2ϩ concentration ([Ca 2ϩ ]cyt) was measured in single human PASMC and PAEC using ratiometric Ca 2ϩ label fura 2-AM. Cells grown on cover slips were loaded with fura 2-AM (4 M) in the dark at room temperature for 30 min before being transferred to a perfusion chamber on the Nikon TMS microscope stage. Loaded cells were superfused with modified Krebs solution (MKS) for 30 min at 32°C to remove residual extracellular dye and to allow intracellular esterases to cleave cytosolic fura 2-AM into active fura 2. The MKS contained (in mM) 138 NaCl, 4.7 KCl, 1.2 NaH 2PO4, 1.2 MgSO4, 10 HEPES, 1.8 CaCl2, and 10 glucose, pH 7.4. In Ca 2ϩ -free MKS, CaCl2 was replaced by equimolar MgCl2. Fura 2 fluorescence (excited by a xenon lamp at 510 nm and emission recorded at 340 and 380 nm) was collected using a ϫ40 Nikon UV-Fluor objective and a charge-coupled device camera. The fluorescence signals emitted from the cells were captured every 2 s using InCytIM2 software (Intracellular Imaging). [Ca 2ϩ ]cyt was measured as the ratio of fura 2 fluorescence emission at 340 nm and 380 nm (F 340/F380) normalized to baseline (F0) and is reported as F/F0.
RT-PCR. Total RNA was extracted from human PASMC and PAEC following cell lysis with TRIzol (Invitrogen). Addition of chloroform followed by centrifugation was used to separate the aqueous phase containing the RNA; RNA was then precipitated using isopropyl alcohol. RNA concentration and quality were determined from OD260 -280 measurements. SuperScript First-Strand Synthesis System (Invitrogen) was used to synthesize cDNA. RNA (2 g) was first treated with DNase I and the reaction stopped with 10% 25 mM EDTA (65°C 10 min). The reverse transcription (RT) reaction consisted of three phases: 1) 10 l DNase-treated RNA, oligo(dT) dNTP (1 l, 10 mM) at 65°C for 5 min; 2) first-strand buffer (4 l, 5ϫ), 0.1 M DTT (2 l), RNaseOUT heated to 42°C for 2 min; and 3) SuperScript II reverse transcriptase added to the samples for 50 min at 42°C and 15 min at 70°C. For negative controls, DNase-RNase-free H 2O was added to the RT reaction instead of SuperScript II.
Platinum PCR SuperMix (Invitrogen) was used to perform all PCR reactions. The mixture contained 22 U/ml complexed recombinant Taq DNA polymerase with Platinum Taq antibody, 22 mM Tris ⅐ HCl (pH 8.4), 55 mM KCl, 1.65 mM MgCl 2, 220 M dNTP, and stabilizers. Total volume of each reaction tube was 25 l. PCR primer sequences are included in Table 1 . The specificity of the sense and antisense oligonucleotides were examined using the NCBI-BLAST program. PCR was performed according to the following sequence: 5 min at 95°C followed by 35°C cycles of denaturation at 95°C for 30 s, primer annealing at 55 for 30 s, and primer extension at 72°C for 20 s and ending with 72°C for 7 min. PCR products were electrophoresed through 1.2% agarose gels containing 10 M Gelstar Nucleic Acid stain (Lonza) and were visualized by ultraviolet illumination. A positive control GAPDH was used to semiquantify the RT-PCR products. The net intensity values of cDNA bands was measured by Image J software, and the PCR products were normalized to the GAPDH product from the same cDNA sample and PCR reaction and run on the same gel.
Chemicals. Human thrombin was purchased from Enzyme Research Laboratories (South Bend, IN). All other chemicals were purchased from Sigma (St. Louis, MO) and prepared as stock solutions in their respective solvents. CPA was dissolved in DMSO to make a stock solution of 10 mM. Aliquots of the stock solution were then diluted to the final concentration and used the day of each experiment. pH values were readjusted to 7.4 after the addition of drugs to the Ca 2ϩ -free solution. Statistics and data analysis. Data are expressed as means Ϯ SE; n represents the number of cells. Statistical analysis was performed using paired Student's t-test. Differences were considered to be significant at P Ͻ 0.05.
RESULTS
Comparable PAR expression in PASMC and PAEC. PASMC and PAEC from normal subjects (Fig. 1A) were first evaluated for expression of PAR subtypes. The mRNA expression for all PAR subtypes (PAR 1-4) was present in both PASMC (Fig.  1B) and PAEC (Fig. 1C) . Semiquantitative analysis, when expression was normalized to GAPDH intensity ( Fig. 1D ), indicated no statistically significant differences in receptor subtype expression between the two cell lines. Indeed, PAR-2 and PAR-3 expression levels were higher in PASMC, and PAR-4 expression was higher in PAEC. Overall, these data indicate that the mRNA expression level of all PAR is comparable between PASMC and PAEC.
Thrombin causes kinetically different [Ca 2ϩ ] cyt transients in PAEC and PASMC. We directly compared the thrombininduced increases in [Ca 2ϩ ] cyt in PASMC and PAEC. Application of thrombin (10 nM) caused large transient increases in [Ca 2ϩ ] cyt in both cell types ( Fig. 2A) , but the transients differed with respect to both their amplitude and duration (Fig. 2B) . Peak amplitude of the Ca 2ϩ transient was significantly greater in PASMC (2.72 Ϯ 0.11 F/F 0 , n ϭ 11) than in PAEC (2.28 Ϯ 0.12 F/F 0 , n ϭ 19; P Ͻ 0.05). Thrombin-induced Ca 2ϩ tran- Figure 3A shows data from PASMC and PAEC exposed to thrombin in the presence of 10 M CPA, an inhibitor of the SR/ER Ca 2ϩ -ATPase pump that depletes Ca 2ϩ stored in the IP 3 -sensitive SR/ER. Detailed analysis of these experiments showed that resting [Ca 2ϩ ] cyt was significantly lower in PASMC than in PAEC (P Ͻ 0.001) (Fig. 3Ba) . In both cell types, CPA caused a transient [Ca 2ϩ ] cyt increase in the absence of extracellular Ca 2ϩ (Fig. 3 , A and Bb), but its amplitude was significantly greater in PASMC (1.08 Ϯ 0.09 F/F 0 ) than in PAEC (0.42 Ϯ 0.04; P Ͻ 0.001). Furthermore, the CPA-induced Ca 2ϩ transient showed different kinetics in PASMC and PAEC (Fig.  3C) , reflecting those observed in response to thrombin in Fig.  2 . Subsequent exposure to thrombin in Ca 2ϩ -freeϩCPA solution caused a substantial rapid Ca 2ϩ release in all PAEC, whereas only a very small proportion of PASMC showed a brief, low amplitude response to thrombin (Fig. 3Bc , P Ͻ 0.01). When the thrombin response is expressed as a ratio relative to the CPA-induced Ca 2ϩ release, a significantly higher thrombin-mediated CPA-insensitive Ca 2ϩ release is observed in PAEC (Fig. 3Bd , P Ͻ 0.001). Upon reintroduction of Ca 2ϩ to the perfusate in the presence of CPA, a biphasic capacitative Ca 2ϩ entry (CCE) was observed. The peak and plateau amplitudes of this CCE were significantly greater in PASMC than in PAEC (Fig. 3 , Be and Bf; P Ͻ 0.001). The data suggests that, in addition to causing Ca 2ϩ influx through plasma membrane channels, thrombininduced increases in [Ca 2ϩ ] cyt occur by promoting Ca 2ϩ release from different intracellular stores in PASMC and PAEC. To confirm that the thrombin-mediated signaling pathway, via G protein-coupled receptors (GPCR), was not uncoupled and that the PAR were not desensitized, the experiment in PASMC was repeated in the presence of extracellular Ca 2ϩ (Fig. 4) (Fig. 5) . Depletion of ryanodine-and caffeine-sensitive stores had no effect on the thrombin-induced increase in [Ca 2ϩ ] cyt . These results suggest that thrombin stimulates Ca 2ϩ mobilization from an intracellular store that is not sensitive to caffeine, ryanodine, or CPA.
Thrombin causes rhythmic [Ca 2ϩ ] cyt oscillations in PASMC. In human PASMC, low-concentration thrombin (10 nM) induced [Ca 2ϩ ] cyt oscillations with different frequency and amplitudes (Fig. 6) . Removal of extracellular Ca 2ϩ abolished thrombin-induced Ca 2ϩ oscillations; this effect was reversible, i.e., restoration of extracellular Ca 2ϩ restored thrombin-induced Ca 2ϩ oscillations (Fig. 7, A and B) . Upon removal of Ca 2ϩ , thrombin often triggered a single Ca 2ϩ transient whose amplitude was comparable to that of oscillations observed in Ca 2ϩ -containing perfusate (Fig. 7C) . Finally, CPA effectively blocked thrombin-induced Ca 2ϩ oscillations (Fig. 8) , again indicating that CPA-sensitive intracellular stores are also thrombin-sensitive stores in human PASMC.
Together, the results suggest that thrombin-induced activation of PAR, in addition to calcium influx mechanisms, increases [Ca 2ϩ ] cyt via Ca 2ϩ release from CPA-sensitive SR/ER. The IP 3 -mediated store depletion then causes CCE via storeoperated channels (SOC); however, the incoming Ca 2ϩ is probably directly or rapidly sequestered into the SR/ER to refill Ca 2ϩ into these intracellular stores. In other words, the thrombin-induced Ca 2ϩ oscillations depend on the capacity or levels of Ca 2ϩ in the SR/ER, whereas the store-operated Ca 2ϩ influx plays an important role in refilling the stores so that a "normal" Ca 2ϩ oscillation can occur.
DISCUSSION
In the lung, the formation of fibrotic clots due to the persistence of pulmonary embolisms can lead to vascular injury, and, particularly, to disruption of the endothelial barrier. Such occluding clot regions, typical of chronic thromboembolic pulmonary hypertension, are sites that can accumulate thrombin as well as vasoactive and mitogenic agents produced by circulating platelets or by endothelial cells themselves. In the endothelial monolayer, changes in microvascular permeability or vascular leakage are major downstream effects of altered [Ca 2ϩ ] cyt . In vascular smooth muscle cells, increased [Ca 2ϩ ] cyt can translate into contraction and/or proliferation. Thrombin is known to induce vascular injury predominantly via effects on endothelial cells leading to endothelial barrier dysfunction due to mobilization of Ca 2ϩ and rearrangement of the cytoskeleton (12) . In the current study, we evaluated the impact of thrombin on Ca 2ϩ signaling in human PASMC and PAEC.
Many of the cellular effects of thrombin are consistent with a primary role in vessel wound healing and revascularization (10) and involve a multitude of cell types (i.e., platelets, endothelium, smooth muscle cells, neutrophils, leukocytes, neurons, glial cells) in the systemic response to vascular damage. Thrombin receptors, known as PAR, are members of the G protein superfamily of seven-transmembrane domain receptors. Through binding to PAR expressed on smooth muscle cells (PAR 1-4), thrombin has been shown to modulate Ca 2ϩ signaling, in turn increasing cell proliferation and migration (2). We found that the mRNA expression of all four thrombin-specific PAR subtypes was similar in human PASMC and PAEC (Fig. 1) , although there was a tendency for PASMC to express more PAR-2 and PAR-3 than PAEC, whereas PAEC expressed more PAR-4 than did PASMC. PAR-1 function has been linked to regulation of endothelial barrier function (19, 37) . PAR-2 is also expressed in vascular tissue and highly vascularized organs, where it is purported to play a role in regulating vascular tone (endothelium-dependent relaxation) and the chronic response to vessel inflammation and wound healing (21) . PAR-3, expressed in many cell types, may be involved in the vascular inflammatory response (29) and smooth muscle cell proliferation (7) . Platelet PAR-3 deficiency can also protect against thrombosis in mice (41). Some have even suggested that PAR-3 may act as a cofactor for PAR-4 activation by thrombin, rather than as a functional receptor (28, 41) . PAR-4 itself may have an important role in regulating vascular tone (16) and endothelial cell proliferation (13) . We previously reported that mRNA expression of PAR-1 and PAR-3 was increased in PASMC from idiopathic pulmonary arterial hypertension (IPAH) patients compared with PASMC from normal subjects and normotensive patients (31) . These results suggest that thrombin signaling, at least in PASMC, may be involved in triggering pulmonary vasoconstriction and vascular remodeling in IPAH patients.
In the current study, we showed that thrombin causes significant increases in [Ca 2ϩ ] cyt in both PASMC and PAEC, which could be attributed to both Ca 2ϩ influx and Ca 2ϩ release from the sarcoplasmic/endoplasmic reticulum. Indeed, thrombin has previously been shown to stimulate Ca 2ϩ influx mechanisms, particularly via the canonical transient receptor potential channels, TRPC1 and 6 (1, 33) . Such thrombin-mediated TRPC-dependent elevations in [Ca 2ϩ ] cyt represent an important mechanism of increased intracellular Ca 2ϩ . In addition, we have shown here that thrombin has specific effects on Ca 2ϩ release from intracellular stores that appear to be different in PASMC and PAEC. These complementary studies into the regulation of thrombin-mediated elevations of [Ca 2ϩ ] cyt may indicate an interaction of thrombin-sensitive stores with either different TRPCs or the same TRPCs activated via different mechanisms in the different cell types.
Our findings indicate a substantial thrombin-dependent release of Ca 2ϩ from intracellular stores in both PASMC and PAEC; however, in PASMC this release is entirely CPA sensitive, indicating predominant Ca 2ϩ release from IP 3 -and CPA-sensitive stores in the SR. Thrombin was able to still initiate a rise in intracellular Ca 2ϩ in the presence of extracellular Ca 2ϩ after store depletion by CPA, confirming that the GPCR-mediated signaling pathways were still intact and functional in these cells.
While CPA-and IP 3 -sensitive stores appeared to play major roles in the [Ca 2ϩ ] cyt response to thrombin in PASMC, it was apparent that PAEC possessed another source of Ca 2ϩ . In PAEC, a significant thrombin-mediated Ca 2ϩ release was still present even after pretreatment with a cocktail of CPA, caffeine, and ryanodine, implicating a substantial Ca 2ϩ release from a different intracellular store. These data show that the thrombin-mediated Ca 2ϩ release in PAEC may involve sources in addition to an IP 3 -sensitive ER that can be depleted by CPA: for example, 1) ER stores that cannot be depleted by CPA, and 2) non-ER-based stores. Although we have yet to identify the source, this finding is similar to one we previously described in human PAEC treated with histamine where pretreatment with caffeine, ryanodine, bafilomycin, and FCCP did not abolish histamine-induced Ca 2ϩ transients in PAEC (23) . While the ER/SR represent the largest intracellular store in most excitable and nonexcitable cells (including PASMC and PAEC), mitochondria, Golgi apparatus, lysosomes, peroxisomes, and endosomes all represent other potential Ca 2ϩ sources (25) . We did observe equivalent results in response to thrombin using a similar cocktail (i.e., caffeine, ryanodine, bafilomycin, and FCCP) (Agange and Yuan, unpublished observations). The presence of this additional source of intracellular Ca 2ϩ specific to PAEC and stimulated by two different agonists, histamine and thrombin, may have a significant role in vascular injury in both inflammatory and thromboembolic pulmonary vascular diseases. The activation of such stores by distinct GPCR signaling pathways (histamine G q coupled, PAR either G ␣i , G ␣12/13 , or G q coupled) therefore indicate that this Ca 2ϩ release from a novel intracellular store in PAEC may be important in understanding mechanisms of endothelial dysfunction in pulmonary vascular disease. The data in the current manuscript are supportive of previously published work from our laboratory describing a similar "histamine-releasable store" specific to PAEC. We are continuing to determine the precise nature of this store and to ascertain if these thrombin-and histamineinducible stores are indeed activated via the same specific mechanism in PAEC. Thrombin and histamine have been shown to contribute in different manners to vascular endothelial barrier dysfunction, histamine in a physiological Ca 2ϩ -calmodulin dependent pathway and thrombin by a Ca 2ϩ sensitization, potentially involving protein tyrosine phosphorylation and RhoA activation (39, 40) .
Whole cell Ca 2ϩ oscillations are generally associated with rhythmic cell contraction and vasomotion (24) . In our experiments, we observed Ca 2ϩ oscillations in response to thrombin in several PASMC studied (Figs. 6 -8) . The oscillations varied dramatically in frequency, but not significantly in amplitude. Oscillations could be abolished by removal of extracellular Ca 2ϩ and by treatment with CPA, indicating that their underlying mechanism involved primarily Ca 2ϩ influx from the extracellular space, and that their occurrence is highly regulated by reuptake of Ca 2ϩ into the ER/SR by CPA-sensitive Ca 2ϩ -ATPase pumps. The putative link between Ca 2ϩ influx and ER/SR refilling also indicates that store-operated Ca 2ϩ influx via TRPC is involved. As the oscillations were observed in so few PASMC, and not in PAEC, the physiological role of the Ca 2ϩ oscillations is unclear at this time. Together, our results suggest that the mechanisms underlying thrombin-mediated calcium release are different in PASMC and PAEC. Thrombin causes Ca 2ϩ release from CPA-sensitive IP 3 -modulated stores and Ca 2ϩ influx from the extracellular space potentially via store-operated Ca 2ϩ channels in PASMC;
however, in PAEC, the thrombin-mediated Ca 2ϩ release is predominantly via intracellular stores insensitive to CPA, caffeine, and ryanodine. Finally, we demonstrate that only PASMC exhibit Ca 2ϩ oscillations in response to thrombin, ostensibly due to release-reuptake cycling within the SR. The CPA-, caffeine-, and ryanodine-insensitive Ca 2ϩ release in the PAEC may contribute substantially to thrombin-mediated vascular injury and plays a significant role in endothelial barrier dysfunction in pulmonary diseases such as CTEPH.
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